HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dexamethasone transiently attenuates up-regulation of endostatin/collagen XVIII following traumatic brain injury.

Abstract
Endostatin/collagen XVIII is a specific inhibitor of endothelial proliferation and migration in vitro. It has also been shown to have anti-angiogenic activity and tumor growth inhibitory activity in vivo and in vitro. Here we studied expression of endostatin/collagen XVIII in a rat traumatic brain injury (TBI) model, focusing on the early phase. A significant up-regulation of endostatin/collagen XVIII in TBI began as early as 24 h post-TBI. Double-staining experiment revealed that the major resource of endostatin/collagen XVIII(+) cells in our TBI rat model was a subpopulation of reactivated microglia/macrophages. Our data further showed that dexamethasone attenuated up-regulation of endostatin/collagen XVIII expression at days 1 and 2, but not at day 4, post-TBI, indicating that dexamethasone might possess an early and transient influence to the angiogenesis following TBI.
AuthorsZ-Y Zhang, Z Zhang, U Fauser, M Artelt, M Burnet, H J Schluesener
JournalNeuroscience (Neuroscience) Vol. 147 Issue 3 Pg. 720-6 (Jul 13 2007) ISSN: 0306-4522 [Print] United States
PMID17560042 (Publication Type: Journal Article)
Chemical References
  • Anti-Inflammatory Agents
  • Col23a1 protein, rat
  • Endostatins
  • Dexamethasone
  • Collagen
Topics
  • Animals
  • Anti-Inflammatory Agents (administration & dosage)
  • Brain Injuries (drug therapy, metabolism)
  • Cell Count
  • Collagen (metabolism)
  • Dexamethasone (administration & dosage)
  • Endostatins (metabolism)
  • Male
  • Rats
  • Rats, Inbred Lew
  • Time Factors
  • Up-Regulation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: